Instead of being read visually like some rapid diagnostic tests for Ebola virus, a newly authorized test is the first to use a portable, battery-operated micro reader to reduce the risk of human error in interpreting test results.
The DPP Ebola Antigen System detects viral antigens and provides results in 15 to 20 minutes. It is authorized for use with whole blood from a fingerstick, EDTA venous whole blood, and EDTA plasma. The test should be used in conjunction with other factors such as signs and symptoms of infection or living in a geographic area where Ebola infection prevalence is high.
Voelker R. Rapid Ebola Test Uses Micro Reader to Improve Accuracy. JAMA. 2018;320(23):2413. doi:10.1001/jama.2018.19379
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: